Search Results 1511-1520 of 14691 for anti-TNF drugs

1. Coagulation Factor Viia (Intravenous Route) Before Using - Mayo Clinic

   ... medicines. Anti-Inhibitor Coagulant Complex; Factor XIII; Prothrombin Complex. Other Interactions. Certain medicines should not be used at or around the time of ...

2. HER2-Positive Breast Cancer Clinical Trials - Mayo Clinic Research

   The primary objective of this study is to demonstrate that the combination of palbociclib with anti-HER2 therapy plus endocrine therapy is superior to anti-HER2 ...

3. Head and Neck Cancer Center - Overview - Mayo Clinic

   However, depending on your needs, you may also have access to other drug therapies, such as immunotherapy and targeted drug therapy. Rehabilitation and overall ...

4. Role of Immunity in Efficacy of Chemotherapy Plus Trastuzumab - Mayo Clinic

   Participation eligibility · Age >18 years. · Histological confirmation of clinically HER2+ breast cancer · Scheduled to start anti-HER2 therapy, in combination ...

5. A Study to Evaluate the Safety and Efficacy of CT1812 in Early Alzheimer's Disease - Mayo Clinic

   ... anti-coagulant medication within 90 days of LP. NOTE: low dose aspirin is permitted); degenerative arthritis of the lumbar spine; suspected non ...

6. Aminophylline (Intravenous Route) Description and Brand Names - Mayo Clinic

   Bronchodilators are medicines that relax the muscles in the bronchial tubes (air passages) of the lungs. They relieve cough, wheezing, shortness of breath, and ...

7. About Dr. Kenderian - T Cell Engineering Laboratory - Mayo Clinic Research

   His principal research interests are developing and optimizing novel-engineered cell therapy approaches for the treatment of diseases. Research in the T Cell ...

8. Cabozantinib-S-Malate Compared With Temozolomide or Dacarbazine in Treating Patients With Melanoma of the Eye - Mayo Clinic

   By condition, treatment or drug name. Search ... Drugs used in chemotherapy, such as temozolomide ... anti-cytotoxic T-lymphocyte antigen 4 (CTLA4) ...

9. LIPS-A: Lung Injury Prevention Study with Aspirin - Mayo Clinic

   Participation eligibility · Anti-platelet therapy on admission or within 7 days prior to admission · Presented to outside hospital ED > 12 hrs before arrival at ...

10. Sitagliptin (Oral Route) Before Using - Mayo Clinic

    Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...